New Parkinson's combo drug enters first human safety test
NCT ID NCT07170475
Summary
This study aims to check if a combination of two existing drugs, febuxostat and inosine, is safe for people with Parkinson's disease. It will involve 24 adults with early-stage Parkinson's who will take the pills twice daily for 12 weeks. The main goal is to see how the body handles the drugs and measure certain chemical levels, which will help plan future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fujita Health University
RECRUITINGToyoake, Aichi-ken, 470-1192, Japan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.